http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-509293-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-0033 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 |
| filingDate | 1999-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fedf88b663bc51b1d1e30b524fd8b47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00b83aeb808dcee47f7f6b799e40dbca |
| publicationDate | 2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-509293-A |
| titleOfInvention | 5-Thia-omega-substituted phenyl-prostaglandin E derivatives |
| abstract | A 5-thia-w-substituted phenyl prostaglandin E derivative of the formula I, a wherein R1 is hydroxy, C1-6 alkyloxy or NR6R7 (in which R6 and R7 is, each independently, hydrogen or C 1-4 alkyl), R2 is oxo, halogen or O-COR8 (in which R8 is C1-4 alkyl, phenyl or phenyl (C1-4 alkyl)), R3 is hydrogen or hydroxy R4a and R4b is, each independently, hydrogen or C1-4 alkyl R5 is a substituted phenyl The compounds of this formula can bind strongly to PGE receptors and may therefore be useful in prevention or treatment of a range of diseases including immunological diseases (such as multiple sclerosis), asthma, hypertension and acute hepatitis. |
| priorityDate | 1998-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 196.